溶性TREM2和PRO-C3作为生物标志物的能力,可以预测MASLD活动的变化
Charlotte Wilhelmina Wernberg1,2, Vineesh Indira Chandran3,4, Mette Munk Lauridsen2
1Fibrosis, Fatty Liver and Steatohepatitis Research Center Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
JHEP reports : innovation in hepatology
|July 18, 2025
概括
新的非侵入性测试 (NIT) 在监测代谢功能障碍相关的脂肪肝疾病 (MASLD) 的治疗反应方面表现有前途. 可溶性TREM2,PRO-C3和HOMA-IR水平表明NAFLD活动评分 (NAS) 的改善.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物标志物发现发现
- 代谢疾病 代谢疾病
背景情况:
- 代谢功能障碍相关的脂肪肝疾病 (MASLD) 管理依赖于生活方式的改变和新兴的药物治疗.
- 对于非侵入性测试 (NITs) 来有效监测治疗反应存在关键需求.
- 目前的评估方法通常涉及侵入性肝脏活检,突出显示了对替代品的需求.
研究的目的:
- 评估各种NIT能够反映MASLD患者组织学变化的能力.
- 确定特定的生物标志物是否可以在非酒精性脂肪性肝病 (NAFLD) 活动评分 (NAS) 中至少改善一点.
- 探索可溶性TREM2,原标记物和肝硬度测量的实用性,以评估治疗疗效.
主要方法:
- 173名2型糖尿病或严重肥胖患者接受了重复的肝脏活检和血液采样.
- 测量包括在骨髓细胞2 (sTREM2) 上表达的可溶性触发受体,原体标记物 (PRO-C3,PRO-C4,PRO-C6,PRO-C8,PRO-C18L),纤维扫描,FAST-score,以及对胰岛素抵抗的恒温模型评估 (HOMA-IR).
- 使用比较分析和多变量逻辑回归来评估生物标志物变化与NAS中的组织学变化.
主要成果:
- 根据NAS变化 (p=0.0001) 观察到sTREM2,PRO-C3,HOMA-IR和FAST-score的显著差异.
- 多变量分析显示,sTREM2 + PRO-C3和HOMA-IR预测了NAS的改善 (AUROC>0.75).
- 像FIB-4和NFS这样的传统得分并没有有效地反映NAS的改善 (AUROC <0.60).
结论:
- sTREM2,PRO-C3和HOMA-IR是MASLD患者纳斯改善的有希望的指标.
- 这些生物标志物需要进一步研究,作为监测干预反应的潜在替代标志物.
- 结合sTREM2,PRO-C3或HOMA-IR可能会在临床实践中加强对NAS改善的监测.
更多相关视频
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.9K
08:11Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
Published on: August 7, 2021
4.3K
相关概念视频
MALDI-TOF Mass Spectrometry
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
